CAR-T, Bispecifics or ADCs First? Sequencing Myeloma BCMA-Directed Therapies Explained!

#HTUmyeloma Wondering how to sequence CAR-T cell therapy, antibody-drug conjugates (ADCs), and bispecific antibodies in multiple myeloma treatment? In this video, we break down the current strategies, clinical considerations, and expert insights on optimizing therapy sequencing for better patient outcomes. Whether you're a patient, clinician, researcher, or patient advocate, this guide helps make sense of how these advanced therapies fit together in the fight against myeloma. Stay informed, stay empowered. Don’t forget to like, subscribe, and turn on notifications for more updates in precision medicine and oncology! #MultipleMyeloma #CART #ADCTherapy #BispecificAntibodies #MyelomaTreatment #PrecisionMedicine #Hematology #OncologyEducation Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer! Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_so... Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.